AbbVie’s popular arthritis drug Humira is a powerhouse, producing $14 billion in annual sales to make up 60 percent of the drugmaker’s revenue. However, generic versions of the drug are around the ...
Humira, AbbVie’s anti-inflammatory drug that has dozens of patents and $114 billion in U.S. sales, has a tight grasp on its market. That’s soon to change, The New York Times reported Jan. 28. Since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results